A SPAC I in a proxy filing set a March 1 date for shareholders to vote on a proposed merger with fertility company NewGenIvf.
The target is a full-service fertility services provider in asia. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan.
Announced a year ago today, the transaction values NewGen at an implied enterprise value of approximately $50 million.
A SPAC I initially raised $60 million in February 2022 to target the technology and e-commerce industries with a focus in Asia and on companies with an enterprise value of between $250 million and $600 million, excluding any company in china. Read more.
Source: A SPAC I Calls Meeting for Vote on NewGenIvf Deal
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://spacfeed.com/a-spac-i-calls-meeting-for-vote-on-newgenivf-deal
